Skip to main content
Clinical Trials/DRKS00023475
DRKS00023475
Recruiting
未知

Evaluation of the intraoperative radiotherapy (IORT) in pancreatic adenocarcinoma. IOPANCA (IOrt in PANcreatic Cancer) - IOPANCA

niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde0 sites25 target enrollmentApril 13, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
C25
Sponsor
niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde
Enrollment
25
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 13, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde

Eligibility Criteria

Inclusion Criteria

  • 1\. Before registration, patient's written informed consent has been obtained
  • 2\. Age \= 18 years, male and female patients
  • 3\. Legal capacity, patient is able to understand the nature, significance, and consequences of the study
  • 4\. Surgical and medical operability
  • 5\. WHO performance status \= 2

Exclusion Criteria

  • 1\. Prior radiotherapy to the region(s) to be treated
  • 2\. Chemotherapy and/or targeted treatment within 2 weeks before the start of SBRT
  • 3\. Presence of infiltration of OARs such as tracheal, oesophageal infiltration or infiltration of small/large bowel or stomach
  • 4\. Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow\-up schedule; those conditions should be discussed with the patient before registration in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials